These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23024026)

  • 41. Identification of proteins responsible for the development of adriamycin resistance in human gastric cancer cells using comparative proteomics analysis.
    Yang YX; Hu HD; Zhang DZ; Ren H
    J Biochem Mol Biol; 2007 Nov; 40(6):853-60. PubMed ID: 18047778
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Reversal effect and its mechanism of ampelopsin on multidrug resistance in K562/ADR cells].
    Ye J; Zheng Y; Liu D
    Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(6):761-5. PubMed ID: 19624024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [VEGF shRNA enhances the sensitivity of multidrug-resistant leukemia cells to anticancer agent].
    Shen HL; Fang LL; Chen C; Fang XJ; Chen QY; Li J; Xu WL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):34-9. PubMed ID: 21362217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reversal effect of itraconazole on adriamycin and etoposide resistance in human leukemia cells.
    Kurosawa M; Okabe M; Hara N; Kawamura K; Suzuki S; Sakurada K; Asaka M
    Ann Hematol; 1996 Jan; 72(1):17-21. PubMed ID: 8605275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quercetin enhances adriamycin cytotoxicity through induction of apoptosis and regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase/c-Jun N-terminal kinase signaling in multidrug-resistant leukemia K562 cells.
    Chen FY; Cao LF; Wan HX; Zhang MY; Cai JY; Shen LJ; Zhong JH; Zhong H
    Mol Med Rep; 2015 Jan; 11(1):341-8. PubMed ID: 25339540
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of annexin A1 in multidrug resistance of K562/ADR cells identified by the proteomic study.
    Zhu F; Wang Y; Zeng S; Fu X; Wang L; Cao J
    OMICS; 2009 Dec; 13(6):467-76. PubMed ID: 20001861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chaetominine reduces MRP1-mediated drug resistance via inhibiting PI3K/Akt/Nrf2 signaling pathway in K562/Adr human leukemia cells.
    Yao J; Wei X; Lu Y
    Biochem Biophys Res Commun; 2016 May; 473(4):867-873. PubMed ID: 27038543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Indomethacin overcomes doxorubicin resistance by decreasing intracellular content of glutathione and its conjugates with decreasing expression of gamma-glutamylcysteine synthetase via promoter activity in doxorubicin-resistant leukemia cells.
    Asano T; Tsutsuda-Asano A; Fukunaga Y
    Cancer Chemother Pharmacol; 2009 Sep; 64(4):715-21. PubMed ID: 19153736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased expression of nucleophosmin/B23 increases drug sensitivity of adriamycin-resistant Molt-4 leukemia cells through mdr-1 regulation and Akt/mTOR signaling.
    Wang L; Chen B; Lin M; Cao Y; Chen Y; Chen X; Liu T; Hu J
    Immunobiology; 2015 Mar; 220(3):331-40. PubMed ID: 25457413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional roles of glycogene and N-glycan in multidrug resistance of human breast cancer cells.
    Ma H; Miao X; Ma Q; Zheng W; Zhou H; Jia L
    IUBMB Life; 2013 May; 65(5):409-22. PubMed ID: 23441047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lysophosphatidate signaling stabilizes Nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: implications for cancer treatment.
    Venkatraman G; Benesch MG; Tang X; Dewald J; McMullen TP; Brindley DN
    FASEB J; 2015 Mar; 29(3):772-85. PubMed ID: 25398768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation of multidrug resistance gene (mdr-1) with antisense oligodeoxynucleotides.
    Liu C; Qureshi IA; Ding X; Shan Y; Huang Y; Xie Y; Ji M
    Clin Sci (Lond); 1996 Jul; 91(1):93-8. PubMed ID: 8774266
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suppression of P-glycoprotein expression by antipsychotics trifluoperazine in adriamycin-resistant L1210 mouse leukemia cells.
    Shin SY; Choi BH; Kim JR; Kim JH; Lee YH
    Eur J Pharm Sci; 2006 Jul; 28(4):300-6. PubMed ID: 16707254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of Bmi-1 on Multidrug Resistance in K562/ADR Cells and Its Mechanisms].
    Zhao BX; Liu SQ; Dong SC; Jing RN; Meng XX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):758-766. PubMed ID: 32552933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Silencing of the ABCC4 gene by RNA interference reverses multidrug resistance in human gastric cancer.
    Zhang G; Wang Z; Qian F; Zhao C; Sun C
    Oncol Rep; 2015 Mar; 33(3):1147-54. PubMed ID: 25572969
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Indomethacin overcomes doxorubicin resistance with inhibiting multi-drug resistance protein 1 (MRP1).
    Matsunaga S; Asano T; Tsutsuda-Asano A; Fukunaga Y
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):348-53. PubMed ID: 16331495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. WYE-354 restores Adriamycin sensitivity in multidrug-resistant acute myeloid leukemia cell lines.
    Ibrahim SM; Bakhashab S; Ilyas AM; Pushparaj PN; Karim S; Khan JA; Abuzenadah AM; Chaudhary AG; Al-Qahtani MH; Ahmed F
    Oncol Rep; 2019 Jun; 41(6):3179-3188. PubMed ID: 30942458
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Knockdown of SALL4 inhibits the proliferation and reverses the resistance of MCF-7/ADR cells to doxorubicin hydrochloride.
    Chen YY; Li ZZ; Ye YY; Xu F; Niu RJ; Zhang HC; Zhang YJ; Liu YB; Han BS
    BMC Mol Biol; 2016 Mar; 17():6. PubMed ID: 26935744
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin.
    Liu Y; Du F; Chen W; Yao M; Lv K; Fu P
    Exp Cell Res; 2013 Dec; 319(20):3140-9. PubMed ID: 24012960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapamycin-Mediated mTOR Inhibition Reverses Drug Resistance to Adriamycin in Colon Cancer Cells.
    Ma Q; Chang Z; Wang W; Wang B
    Hepatogastroenterology; 2015 Jun; 62(140):880-6. PubMed ID: 26902021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.